129 related articles for article (PubMed ID: 14969606)
1. Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
He J; Liu G; Zhang S; Rusckowski M; Hnatowich DJ
Cancer Biother Radiopharm; 2003 Dec; 18(6):941-7. PubMed ID: 14969606
[TBL] [Abstract][Full Text] [Related]
2. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
[TBL] [Abstract][Full Text] [Related]
3. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
[TBL] [Abstract][Full Text] [Related]
4. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406
[TBL] [Abstract][Full Text] [Related]
5. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
[TBL] [Abstract][Full Text] [Related]
6. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
[TBL] [Abstract][Full Text] [Related]
7. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
He J; Liu G; Dou S; Gupta S; Rusckowski M; Hnatowich D
Bioconjug Chem; 2007; 18(3):983-8. PubMed ID: 17385902
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
Chen X; Dou S; Liu G; Liu X; Wang Y; Chen L; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2008 Aug; 19(8):1518-25. PubMed ID: 18646837
[TBL] [Abstract][Full Text] [Related]
9. Pretargeting with amplification using polymeric peptide nucleic acid.
Wang Y; Chang F; Zhang Y; Liu N; Liu G; Gupta S; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2001; 12(5):807-16. PubMed ID: 11562199
[TBL] [Abstract][Full Text] [Related]
10. Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
He J; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich D
Mol Pharm; 2010 Aug; 7(4):1118-24. PubMed ID: 20507096
[TBL] [Abstract][Full Text] [Related]
11. Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.
Liu G; Dou S; Pretorius PH; Liu X; Chen L; Rusckowski M; Hnatowich DJ
Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):333-40. PubMed ID: 20639818
[TBL] [Abstract][Full Text] [Related]
12. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
[TBL] [Abstract][Full Text] [Related]
13. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ
Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173
[TBL] [Abstract][Full Text] [Related]
14. Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
Liu G; Dou S; Pretorius PH; Liu X; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):272-80. PubMed ID: 17909792
[TBL] [Abstract][Full Text] [Related]
15. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
16. A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
[TBL] [Abstract][Full Text] [Related]
17. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
[TBL] [Abstract][Full Text] [Related]
18. Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.
Liu G; Dou S; Mardirossian G; He J; Zhang S; Liu X; Rusckowski M; Hnatowich DJ
Clin Cancer Res; 2006 Aug; 12(16):4958-64. PubMed ID: 16914585
[TBL] [Abstract][Full Text] [Related]
19. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139
[TBL] [Abstract][Full Text] [Related]
20. 90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
Liu G; Dou S; Liu Y; Wang Y; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2011 Dec; 22(12):2539-45. PubMed ID: 21985267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
